Share this:
Inflammatory bowel disease is common, and it is becoming more common in many populations.
Dr. William Faubion Jr., a Mayo Clinic gastroenterologist, says inflammatory bowel disease is an umbrella term that covers Crohn's disease and ulcerative colitis, and that inflammatory bowel disease is an emerging public health problem.
"The most recent estimates would be that, depending on where you live and what region in the world you live, as many as 1 in 250, to 1 in 300 people may be affected with inflammatory bowel disease," says Dr. Faubion.
Dr. Faubion points out that inflammatory bowel disease is a combination of a complex genetic disease and an immunologic disease, as well as environmental variants or triggers.
In this Mayo Clinic Q&A podcast, Dr. Faubion explains that inflammatory bowel disease is very different from irritable bowel syndrome. He also describes symptoms, tests and treatments for inflammatory bowel disease, including how researchers are using artificial intelligence to determine the right medication for each patient.
Watch: The increasing prevalence of inflammatory bowel disease.
Read the full transcript.
__________________________________________
For the safety of its patients, staff and visitors, Mayo Clinic has strict masking policies in place. Anyone shown without a mask was either recorded prior to COVID-19 or recorded in a nonpatient care area where social distancing and other safety protocols were followed.
Share this:
Related articles
Mayo Clinic researchers have identified a diverse range of environmental chemicals in human bile in patients with primary sclerosing cholangitis, a rare, chronic liver disease ...
Irritable bowel syndrome (IBS) can significantly disrupt a person's daily life. Some people suffer in silence because of painful stomach cramps, diarrhea and constipation. These ...
LONDON — Sleeping enough, eating well, exercising and coping with stress are all components of good health, but focusing on all four at once while ...